Your browser doesn't support javascript.
loading
Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma - First Initiators and Switchers.
Hashimoto, Simone; Kroes, Johannes A; Eger, Katrien A; Mau Asam, Pearl F; Hofstee, Hendrik B; Bendien, Sarah A; Braunstahl, Gert Jan; Broeders, Marielle E A C; Imming, Leonie M; Langeveld, Bas; Maitland-van der Zee, Anke H; Oud, Karen T M; Patberg, Kornelis Wiebe; Smeenk, Frank W J M; Romme, Elisabeth A P M; van Bezouw, Maarten J; van de Ven, Marjo J; van Veen, Anneke; van Velzen, Edwin; van Veen, Ilonka H P A A; Weersink, Els J M; Ten Brinke, Anneke; Sont, Jacob K; Bel, Elisabeth H.
Affiliation
  • Hashimoto S; Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: S.Hashimoto@amsterdamumc.nl.
  • Kroes JA; Department of Clinical Pharmacy and Pharmacology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
  • Eger KA; Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Mau Asam PF; Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Hofstee HB; Department of Biomedical Data Sciences, Section Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.
  • Bendien SA; Department of Respiratory Medicine, Haga Teaching Hospital, The Hague, The Netherlands.
  • Braunstahl GJ; Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands.
  • Broeders MEAC; Jeroen Bosch Hospital 's-Hertogenbosch, 's-Hertogenbosch, The Netherlands.
  • Imming LM; Department of Pulmonology, Medisch Spectrum Twente, Enschede, The Netherlands.
  • Langeveld B; Department of Pulmonology, Deventer Ziekenhuis, Schalkhaar, The Netherlands.
  • Maitland-van der Zee AH; Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Oud KTM; Ziekenhuis Gelderse Vallei, Ede, The Netherlands.
  • Patberg KW; Department of Pulmonology, Isala Clinics, Zwolle, The Netherlands.
  • Smeenk FWJM; Department of Pulmonology, Catharina Hospital, Eindhoven, The Netherlands; Department of Educational Development and Research, School of Health Professions Education, Maastricht University, Maastricht, The Netherlands.
  • Romme EAPM; Department of Pulmonology, Rijnstate Hospital, Arnhem, The Netherlands.
  • van Bezouw MJ; Department of Work and Organizational Psychology, University of Amsterdam, Amsterdam, The Netherlands.
  • van de Ven MJ; Department of Pulmonology, Rijnstate Hospital, Arnhem, The Netherlands.
  • van Veen A; Canisius Wilhelmina Ziekenhuis Nijmegen, Nijmegen, The Netherlands.
  • van Velzen E; Department of Respiratory Medicine, Meander Medical Center, Amersfoort, The Netherlands.
  • van Veen IHPAA; Department of Pulmonology, Medisch Spectrum Twente, Enschede, The Netherlands.
  • Weersink EJM; Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Ten Brinke A; Department of Pulmonology, Leeuwarden Medical Center, Leeuwarden, the Netherlands.
  • Sont JK; Department of Biomedical Data Sciences, Section Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.
  • Bel EH; Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Department of Biomedical Data Sciences, Section Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands.
J Allergy Clin Immunol Pract ; 10(8): 2099-2108.e6, 2022 08.
Article in En | MEDLINE | ID: mdl-35487369

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Eosinophilia / Asthma / Biological Products / Anti-Asthmatic Agents Type of study: Clinical_trials / Observational_studies Limits: Adult / Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Eosinophilia / Asthma / Biological Products / Anti-Asthmatic Agents Type of study: Clinical_trials / Observational_studies Limits: Adult / Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2022 Document type: Article Country of publication: